What HPLC-MS Purity Testing Actually Measures

A purity certificate is only useful if you can read it. The two techniques named on most certificates, HPLC and MS, answer different questions, and together they cover both sides of quality: how pure the sample is, and whether it is actually the molecule it claims to be. Understanding what these techniques measure — and what they do not — is essential for evaluating the quality of research peptides and making informed purchasing decisions.

High-Performance Liquid Chromatography (HPLC) separates the components of a sample as it passes through a column. The area under each peak in the resulting chromatogram corresponds to the relative amount of that component, which is why purity is reported as a percentage of peak area. A reading above 99% means the product is overwhelmingly the target peptide, with only trace amounts of anything else. HPLC is the gold standard for measuring peptide purity because it can separate the target peptide from closely related impurities such as deletion sequences, truncated peptides, and oxidation products that may have very similar chemical properties. The technique works by pumping a liquid mobile phase through a column packed with a stationary phase, typically a reversed-phase material such as C18 silica. Different compounds interact differently with the stationary phase, causing them to elute from the column at different times, producing a characteristic chromatogram.

The most common type of HPLC used for peptide analysis is reversed-phase HPLC (RP-HPLC), which uses a nonpolar stationary phase and a polar mobile phase. In this mode, peptides are separated based on their hydrophobicity: more hydrophobic peptides interact more strongly with the stationary phase and elute later, while more hydrophilic peptides elute earlier. The mobile phase typically consists of water and an organic solvent such as acetonitrile, with a small amount of trifluoroacetic acid (TFA) added to improve peak shape and reproducibility. The separation is achieved by gradually increasing the proportion of organic solvent in the mobile phase (a gradient elution), which causes peptides to elute in order of increasing hydrophobicity. The eluting peptides are detected by a UV detector, typically set at 214 nm (which detects the peptide bond) or 280 nm (which detects aromatic amino acids such as tryptophan and tyrosine).

The purity calculation from an HPLC chromatogram is based on the relative area of the main peak compared to the total area of all peaks. This is typically done using integration software that automatically identifies and integrates each peak in the chromatogram. The purity is then calculated as (main peak area / total peak area) × 100%. While this method is generally accurate, it has some limitations. For example, if an impurity does not absorb UV light at the detection wavelength, it will not be detected and will not be included in the purity calculation. Similarly, if two compounds co-elute (elute at the same time), their peaks will overlap and the purity calculation may be inaccurate. For these reasons, HPLC purity should be considered an estimate rather than an absolute value, and it should be interpreted in conjunction with other analytical techniques such as mass spectrometry.

Mass Spectrometry (MS) answers the identity question. By measuring the mass-to-charge ratio of the ionized molecules, the instrument derives an experimental molecular weight that can be compared with the theoretical value calculated from the peptide's sequence. A close match — typically within one Dalton — confirms the synthesized chain has the intended composition. Mass spectrometry is an indispensable tool for peptide analysis because it provides definitive information about the identity of the peptide, confirming that the correct sequence was synthesized and that no major modifications or errors occurred during synthesis. The technique works by ionizing the peptide molecules, accelerating them through an electric field, and then measuring their mass-to-charge ratio based on their trajectory in a magnetic or electric field.

There are several types of mass spectrometry commonly used for peptide analysis, each with its own advantages and limitations. Electrospray ionization (ESI) is the most widely used technique for peptide analysis because it can produce multiply charged ions, which allows for the analysis of large molecules such as peptides and proteins on instruments with a limited mass-to-charge range. ESI is also easily coupled with HPLC, allowing for online analysis of peptides as they elute from the column (LC-MS). Matrix-assisted laser desorption/ionization (MALDI) is another common ionization technique, which uses a laser to desorb and ionize peptides from a crystalline matrix. MALDI typically produces singly charged ions, which simplifies the mass spectrum but limits the size of molecules that can be analyzed. Both ESI and MALDI are soft ionization techniques that minimize fragmentation, allowing for accurate measurement of the intact molecular weight.

The accuracy of mass spectrometry measurements depends on the type of instrument used. Low-resolution instruments such as single quadrupole mass spectrometers typically have an accuracy of ±0.5 to ±1 Da, which is sufficient for confirming the identity of most peptides. High-resolution instruments such as time-of-flight (TOF), Orbitrap, or Fourier-transform ion cyclotron resonance (FT-ICR) mass spectrometers can achieve accuracies of ±0.01 Da or better, allowing for the determination of elemental composition and the detection of subtle modifications such as oxidation or deamidation. For most routine peptide analysis, a low-resolution instrument is sufficient to confirm identity, as the difference between the correct peptide and common synthesis errors (such as a single amino acid deletion or substitution) is typically several Daltons, well within the detection limit of even a low-resolution instrument.

In addition to confirming the identity of the intact peptide, mass spectrometry can also be used to determine the peptide sequence through a technique called tandem mass spectrometry (MS/MS). In this approach, the peptide ions are first selected by the first mass analyzer, then fragmented by collision with an inert gas (collision-induced dissociation, CID), and the resulting fragment ions are analyzed by the second mass analyzer. The fragmentation pattern produces a series of ions that correspond to cleavage at different peptide bonds, allowing the sequence to be reconstructed. This technique is particularly useful for verifying the sequence of custom peptides or for identifying unknown peptides in a sample. However, for routine quality control of catalog peptides, a simple mass measurement is usually sufficient to confirm identity.

What a certificate does not tell you is biological activity or sterility. Purity testing confirms chemistry, not function. For research workflows that require sterile material, look for separate documentation covering filtration or aseptic processing. It is also important to recognize that HPLC and MS are complementary techniques, each providing a different piece of the quality puzzle. HPLC tells you how pure the sample is, but it does not tell you what the impurities are or whether the main component is actually the target peptide. MS tells you whether the target peptide is present, but it does not tell you how pure the sample is or how much of the sample is the target peptide. Together, these techniques provide a comprehensive picture of peptide quality, confirming both identity and purity.

There are also several other analytical techniques that may be used to characterize peptides, depending on the specific application and the level of characterization required. Amino acid analysis (AAA) can be used to determine the amino acid composition of the peptide, providing an independent verification of the sequence and an accurate measurement of the peptide concentration. Nuclear magnetic resonance (NMR) spectroscopy can be used to determine the three-dimensional structure of the peptide in solution, although this is typically only done for peptides of particular interest. Endotoxin testing (LAL assay) may be performed for peptides intended for in vivo use, as endotoxin contamination can cause inflammatory responses. Water content analysis (Karl Fischer titration) can be used to determine the residual moisture in the lyophilized powder, which is important for stability. While these additional tests are not typically included on a standard certificate of analysis, they may be available upon request for an additional fee.

When evaluating a certificate of analysis, it is important to look beyond just the purity number and consider the full context of the testing. Key details to examine include: the name and location of the testing laboratory (independent laboratories are generally more credible than in-house testing), the date of testing (fresh certificates are more meaningful than old ones), the lot number (which should match the lot number on your vial), the analytical method used (reversed-phase HPLC with UV detection is the standard for purity), and the identity confirmation method (ESI-MS or MALDI-TOF are the standards for identity). It is also useful to look at the actual chromatogram and mass spectrum, if they are provided, rather than just the numerical results, as this can reveal potential issues such as co-eluting peaks or unexpected masses that may not be apparent from the numbers alone.

In summary, HPLC and MS are the two foundational techniques for evaluating peptide quality, each providing essential but complementary information. HPLC separates the components of a sample and measures purity as a percentage of peak area, with readings above 99% indicating high-purity material. MS confirms identity by measuring the molecular weight and comparing it with the theoretical value calculated from the sequence, with a match within one Dalton typically considered confirmation. Together, these techniques answer the two most important questions about peptide quality: is it pure, and is it the right molecule? However, neither technique measures biological activity or sterility, and researchers should be aware of these limitations when interpreting certificates of analysis. By understanding what these techniques measure — and what they do not — researchers can make informed decisions about peptide quality and select suppliers that provide comprehensive, reliable analytical documentation.

Dr. James Mitchell, Ph.D.

Research Scientist · Biochemical Engineering

Dr. Mitchell has over 15 years of experience in peptide synthesis and analytical chemistry. He received his Ph.D. in Biochemical Engineering from MIT and has published over 40 peer-reviewed papers on peptide therapeutics and drug delivery systems.